Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML (RNA-Seq)

The effect of TRAF6 loss on the gene expression profiles in leukemia cells I

Gene expression profile of human leukemic cell line with cMyc mutations

Gene expression profile of human leukemic cell line treated with TLR1/2 agonist.

RNA sequencing MOLM-13 cells treated with the UBE2N inhibitor UC-764864 or DMSO control

Gene expression profile of mouse hematopoieitic progenitor cell lines with inducible loss of Ddx41 expression

RNA sequence between miR-155KONf1KO and Nf1KO

Cdkn2a loss in a model of neurofibroma demonstrates stepwise tumor progression to atypical neurofibroma and MPNST

Gene expression profile of HSPC with cell-intrinsic innate immune signaling activation after LPS treatment